EP 4009794 A1 20220615 - ANTIPARASITIC FORMULATION OF BACILLUS THURINGIENSIS SPORES AND/OR PROTEINS FOR THE TREATMENT OF PARASITES OF THE CALIGIDAEFAMILY IN FISH
Title (en)
ANTIPARASITIC FORMULATION OF BACILLUS THURINGIENSIS SPORES AND/OR PROTEINS FOR THE TREATMENT OF PARASITES OF THE CALIGIDAEFAMILY IN FISH
Title (de)
ANTIPARASITÄRE FORMULIERUNG VON BACILLUS-THURINGIENSIS-SPOREN UND / ODER PROTEINEN ZUR BEHANDLUNG VON PARASITEN DER CALIGIDAE-FAMILIE BEI FISCHEN
Title (fr)
FORMULATION ANTIPARASITAIRE DE SPORES ET/OU DE PROTÉINES DE BACILLUS THURINGIENSIS POUR LE TRAITEMENT DE PARASITES DE LA FAMILLEDES CALIGIDAE CHEZ LES POISSONS
Publication
Application
Priority
- US 201962885034 P 20190809
- IB 2020057511 W 20200810
Abstract (en)
[origin: WO2021028817A1] The claimed invention relates to the development of an antiparasitic formulation or composition based on Bacillus thuringiensis spores and/or recombinant Cry proteins of the same bacterium, administered together or each separately, for the treatment of the infection caused by parasites (sea lice) of the Caligidae family in fish. In addition, the development includes a method for treating a sea lice infestation, wherein said antiparasitic composition is administered to fish. Spores are produced under optimized fermentation conditions and Cry proteins obtained from prokaryotic or eukaryotic expression systems.
IPC 8 full level
A01N 63/23 (2020.01); A01P 15/00 (2006.01)
CPC (source: DK EP)
A01N 63/23 (2020.01 - DK EP)
Citation (search report)
See references of WO 2021028817A1
Designated contracting state (EPC)
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated extension state (EPC)
BA ME
DOCDB simple family (publication)
WO 2021028817 A1 20210218; DK 202270092 A1 20220511; EP 4009794 A1 20220615
DOCDB simple family (application)
IB 2020057511 W 20200810; DK PA202270092 A 20220308; EP 20756975 A 20200810